<DOC>
	<DOCNO>NCT01888237</DOCNO>
	<brief_summary>The purpose study compare efficacy 1-day high dose PPI-based triple therapy vs. 10-day sequential therapy Helicobacter pylorus eradication functional dyspepsia patient .</brief_summary>
	<brief_title>High Dose PPI Triple Therapy Versus Sequential Therapy Helicobacter Pylori Eradication</brief_title>
	<detailed_description>Background : Helicobacter pylorus ( HP ) play important role pathogenesis chronic gastritis , peptic ulcer disease well gastric cancer . Helicobacter pylori eradication critical strategy reduce aforementioned condition . Proton-pump inhibitor ( PPI ) -based triple therapy ( Standard dose PPIs+ Clarithromycin 1g/D + Amoxycillin 2g/D Metronidazole 800 mg/D ) recommend frontline treatment current guideline HP eradication , Thai Second Asia-Pacific Consensus Guideline H.pylori 2009 . Unfortunately , report unacceptably low eradication rate ( &lt; 85 % ) regimen tertiary care hospital Thailand . This occurrence surprise worldwide efficacy regimen decrease 50-75 % . Of , Clarithromycin resistance major cause treatment failure . Sequential therapy ( ST ) consist standard dose PPIs + amoxycillin 2 g/D 5 day 5 additional day clarithromycin 1g/D + metronidazole 800 mg/D propose increase efficacy HP eradication . A recent meta-analysis three thousand population reveal high eradication rate PPI-based triple therapy ( TT ) . A consistent finding Thailand report impressive success rate ST HP eradication 95 % . Therefore , update guideline recommend use ST , TT , first line regimen . However , ST complicate regimen patient follow . This might cause low adherence rate clinical practice well development drug resistance near future . Interestingly , PPI pivotal regimen HP eradication . There evidence sustain high intragastric pH major therapeutic determinant HP eradication . Other factor include inflammatory cytokine polymorphism , especially IL-1B-511 T/T genotype PPIs metabolizer , determinant eradication affect gastric acid secretion mucosal inflammation . Hence , high dosage PPIs justify eradicate HP . This show recent meta-analysis high dose PPI well standard dose PPI triple therapy HP eradication HP . Our study aim compare efficacy ST high dose PPI TT . Secondary outcome include comparison adherence adverse event regimen , determine prevalence clarithromycin resistance HP determine improvement dyspeptic symptom HP eradication Primary Aim/Objective : To evaluate eradication rate Helicobacter pylori infection functional dyspepsia patient amongst Thai population , compare 10-day sequential regimen ( lansoprazole 30 mg b.d . plus amoxicillin 1000 mg b.d . 5 day lansoprazole 30 mg b.d. , metronidazole 400 mg b.d . clarithromycin 500 mg b.d . remain 5 day ) 10-day high dose PPI-based triple regimen ( lansoprazole 60 mg b.d . plus clarithromycin 500 mg b.d . amoxycillin 1000 mg b.d . 10 day )</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Stomach Diseases</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Functional dyspepsia patient ( Rome III ) rapid urease test positive Age â‰¥ 18 year old No history HP eradication Recent use PPI , H2RA , NSAID , Antibiotics within 2 week Currently use anticoagulant ketoconazole C/I gastric biopsy History gastric surgery Comorbidity : ESRD , advance cirrhosis , AIDS , stroke ( bed ridden ) Pregnancy lactation Allergy study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Dyspepsia</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Clarithromycin resistance</keyword>
	<keyword>Other Specified Disorders Function Stomach</keyword>
</DOC>